horizon subgroup analyses: melfufen and dexamethasone in r/r mm
Published 3 years ago • 58 plays • Length 6:19Download video MP4
Download video MP3
Similar videos
-
2:27
subgroup analyses in the horizon trial of melflufen plus dexamethasone in r/r myeloma
-
4:05
horizon study: emd subgroup analysis
-
4:30
horizon: melflufen dexamethasone in r/r myeloma
-
2:40
anchor: melflufen in r/r mm
-
4:45
horizon: melflufen & dexamethasone in myeloma
-
1:06
long-term outcomes of the ocean study: melflufen is superior to pomalidomide in r/r myeloma
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
2:42
yumizen h550e and h500e hematology & esr analyzers - horiba
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
19:49
neurology video journal club episode 2: endoluminal biopsy for molecular profiling of human bavms
-
2:09
melflufen in patients with refractory mm: updated analysis of horizon
-
3:13
horizon: melflufen plus dexamethasone shows efficacy in r/r myeloma
-
8:20
updates on the horizon study: melflufen in r/r multiple myeloma
-
5:07
a new horizon: melflufen for r/r multiple myeloma
-
4:56
melflufen for myeloma: horizon
-
2:21
horizon (op-106): melflufen plus dexamethasone
-
2:31
gene expression profiles in subtype characterization and disease evolution of wm
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
8:40
lenalidomide, mutations & mds outcomes
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸